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An amide hydrogen bond templated [1]rotaxane displaying a 
peptide motif – demonstrating an expedient route to synthetic 
mimics of lasso peptides† 
Matthew J. Young,‡a Geoffrey R. Akiena and Nicholas H. Evans*a
The rapid synthesis of an amide hydrogen bond templated [1]rotaxane is reported – demonstrating a potential pathway to 
synthetic analogues of lasso peptides. The structures of the [1]rotaxane and its unthreaded isomer have been characterized 
by NMR spectroscopy and modelled using DFT calculations.
Introduction
Lasso peptides are a fascinating class of structurally unusual 
peptides consisting of a polypeptide chain that threads its “tail” 
through a macrolactam “ring” (Figure 1).1 Due to their 
entangled structure, lasso peptides have been found to evade 
degradation by enzymes, and examples have been shown to 
possess a number of useful bioactive characteristics, including 
antimicrobial activity,2 receptor antagonism3 and enzyme 
inhibition.4 The total synthesis of lasso peptides is in its infancy, 
with the first chemical synthesis of a lasso peptide having only 
very recently been reported.5 However, it has been established 
that the conformationally constrained amino acids displayed in 
the “loop region” (see Figure 1) are important in determining 
the biological activity of a lasso peptide.6 Synthetic 
[1]rotaxanes7 are structurally equivalent to lasso peptides, but 
examples that display peptide sequences are rare.8,9
Figure 1: Schematic representation of structure of a lasso peptide and [1]rotaxane.
Recently we have rapidly prepared [2]rotaxanes10-12 by use 
of hydrogen bond templation13 and CuAAC click chemistry to 
stopper a simple amide half-axle component threaded through 
an isophthalamide macrocycle.14 Here we are reporting an 
adaptation of this method to rapidly prepare a [1]rotaxane 
displaying a Gly-Gly-Gly-Gly peptide sequence within the key 
loop region, by appending and then cyclizing a peptide chain on 
a novel “scaffold” [2]rotaxane. Successful preparation of the 
target [1]rotaxane was confirmed by NMR spectroscopy and 
mass spectrometry. Structural comparison with the non-
interlocked isomer of the [1]rotaxane has also been undertaken 
by NMR spectroscopy and DFT calculations.
When compared to prior work from the laboratories of 
Coutrot8 and Bode9, the synthetic route reported here has the 
potential to generate better mimics of naturally occurring lasso 
peptides. In the previous cases, the entangled structure arises 
from the non-amide templation of a protonated ammonium 
passing through a 24-crown-8 macrocycle. Here, amide motifs 
(used to template formation of the interlocked structure 
through the carbonyl O atom of the axle to the isophthalamide 
N-Hs of the macrocycle) are to be found in both the axle and 
ring components – not just the peptide sequence in the loop 
region.
Results and discussion
The synthesis of [1]rotaxane 6 is presented in Scheme 1. All 
novel compounds were characterized by NMR spectroscopy (1H, 
13C and where applicable 19F), IR spectroscopy and high 
resolution mass spectrometry. Scaffold [2]rotaxane 4 was 
prepared using azide 1, alkyne 2 and amino macrocycle 3. Azide 
1 was synthesized according to our previously reported 
procedures in two chromatography-free steps.10 Novel alkyne 2 
was prepared in four chromatography-free steps (see ESI†, page 
S3), with inclusion of a glycine unit as part of 2 to guarantee 
sufficient bulk for the rotaxane stopper. Novel amino 
macrocycle 3 was synthesized in four steps from commercially 
available starting materials (see ESI†, pages S6 & S9).§a.Department of Chemistry, Lancaster University, Lancaster, LA1 4YB. UK.
† Electronic Supplementary Information (ESI) available: Further experimental 
procedures; copies of spectral characterization data; crystallographic data for 
macrocycle 3 (CCDC 1995143); details of computational modelling. See 
DOI: 10.1039/x0xx00000x.
‡ Current address: Institute of Organic Chemistry, Albert-Ludwigs-University of 
Freiburg, Albertstrasse 21, 79104 Freiburg, Germany.
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[2]Rotaxane 4 was synthesized using our recently reported 
hydrogen bond templated strategy.10-12 Macrocycle 3 was 
dissolved in CH2Cl2 in the presence of 1.1 equivalents of azide 1 
and 1.1 equivalents of alkyne 2. Catalytic [Cu(CH3CN)4]BF4 and 
TBTA and 1.2 equivalents of DIPEA were added and the reaction 
stirred overnight at room temperature under an inert 
atmosphere. After aqueous work-up and careful silica 
chromatography, [2]rotaxane 4 was isolated in 27% yield.15
The 1H NMR spectra of [2]rotaxane 4, along with that of non-
interlocked macrocycle 3 and axle 7 (for synthesis of axle 7 see 
ESI†, page S30) are shown in Figure 2. The upfield shift and 
splitting of aromatic macrocycle protons 8 and 9 and the upfield 
shifts of axle protons 17, 20, 21, 22, 23 and 25 in [2]rotaxane 4 
compared to macrocycle 3 and axle 7 are consistent with the 
threading of the axle component through the macrocycle. The 
downfield shift of internal isophthalamide proton 4 is indicative 
of hydrogen bonding to the carbonyl oxygen of the axle amide. 
Evidence to support the co-conformation of [2]rotaxane 4 
depicted in Scheme 1 is provided by the appearance of through-
space correlations in the 1H ROESY NMR spectrum between 
Scheme 1: Synthesis of tetra-glycine [1]rotaxane 6 via “scaffold” [2]rotaxane 4, and structures of axle 7 and unthreaded “[1]rotaxane” isomer 8.
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protons 8 and 9 of the macrocycle and axle proton 
environments 17, 20 and 21 (see ESI†, page S16). For 
[2]rotaxane 4, the resonances of macrocyclic protons 6 and 11 
are split due to the directionality of the threaded axle that 
causes the protons attached to the same carbon to become 
inequivalent. In addition, the molecular ion peak [M + Na]+ for 
[2]rotaxane 4 was observed in the positive-ion electrospray 
mass spectrum at m/z = 1209 Da (see ESI†, page S17).
Figure 2: 1H NMR spectra of (a) macrocycle 3, (b) [2]rotaxane 4 and (c) axle 7 (1:1 
CDCl3/CD3OD, 400 MHz, 298 K). For atom labels see Scheme 1.
With [2]rotaxane 4 in-hand, preparation of the target 
[1]rotaxane was executed. Boc-Gly-Gly-Gly was appended to 
the macrocyclic amine group of [2]rotaxane 4 by use of EDC 
coupling in 80% yield (using three equivalents of the protected 
tripeptide). Treatment of Boc-peptide appended [2]rotaxane 5 
with TFA in CH2Cl2 simultaneously removed both the Boc and 
tert-butyl ester. Cyclization was carried out using HATU16 at a 
dilute concentration of 2 mmol/L of deprotected 5 in CH2Cl2 to 
minimize the effect of competing oligomerization reactions, 
with [1]rotaxane 6 being isolated in 34% yield (over two steps 
from 5) after aqueous work-up and silica gel column 
chromatography. Confirmation of the successful isolation of 
target [1]rotaxane 6 was ascertained by NMR spectroscopy and 
mass spectrometry – a molecular ion peak [M + Na]+ for 6 being 
observed in the positive-ion electrospray mass spectrum at m/z 
= 1306 Da (see ESI†, page S24).
To study the structural effects of [1]rotaxane 6 being 
interlocked, the unthreaded analogue 8 was also prepared (for 
details of synthesis see ESI†, page S33). Inspection of the 1H 
NMR spectra (recorded in D6-DMSO due to the very limited 
solubility of 8, Figure 3) reveals the anticipated shielding of 
protons 8, 9, 17, 20, 21, 22 and 25 (but interestingly not 23) and 
deshielding of proton 4 for [1]rotaxane 6 compared to 
unthreaded 8. In addition, the axle amide proton c is notably 
upfield in 6 compared to 8, consistent to being present within 
the shielding macrocyclic cavity of [1]rotaxane 6. There is also 
the expected marked splitting of macrocyclic resonances 6 and 
11 for [1]rotaxane 6 arising from the directionality of the 
threaded axle. Other notable differences in chemical shift 
between the two molecules are for amide proton a (significantly 
greater than for any of the glycine amide protons d-g) and 
aromatic axle proton 27, tentatively attributed to differences in 
hydrogen bonding involving these protons (either 
intramolecularly and/or with the strongly hydrogen bond 
accepting DMSO solvent).
Figure 3: 1H NMR spectra of (a) [1]rotaxane 6 and (b) unthreaded isomer 8 (D6-DMSO, 
400 MHz, 298 K). For atom labels see Scheme 1.
NMR experiments at elevated temperatures provided no 
evidence of dethreading of 6 or threading of 8. However, they 
were used to study variation in the chemical shift of NH 
resonances as a function of temperature, as has been used in 
the structural characterization of proteins in aqueous solution 
(see ESI†, pages S45-S47).17 In aqueous solution, temperature 
coefficients /T >−4.5 ppb/K are attributed to intramolecular 
hydrogen bonds, while those that are more negative 
(<−4.5 ppb/K) are deemed to be freely interacting with solvent. 
The limited literature data for rigid peptides in D6-DMSO is 
consistent with all coefficients being slightly less negative on 
average.18
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For unthreaded 8, all amide temperature coefficients are in 
the range −3.3 to −4.5 ppb/K, which is consistent with relatively 
unrestricted solvent accessibility. For [1]rotaxane 6, the bulk of 
the NH environments have similar coefficients (in the range of 
−3.0 to −4.3 ppb/K) but there are two key exceptions. Axle 
amide c has a coefficient of −1.1 ppb/K implying it is inaccessible 
to solvent and macrocycle protons b have an unusually negative 
coefficient of −6.7 ppb/K. We attribute these deviations to the 
various non-covalent interactions arising from the axle 
component threading through the macrocycle cavity.
Further structural comparison between 6 and 8 was possible 
from 1H diffusion NMR experiments (see ESI†, pages S48 & 
S49).19 For [1]rotaxane 6 the diffusion coefficient 
D = 1.28±0.03e-10 m2s-1, whereas for unthreaded analogue 8 
D = 1.10±0.03e-10 m2s-1. In other words, the threaded 
[1]rotaxane diffuses faster which is consistent with a more 
compact 3D structure in solution. The observed D for both 6 and 
8 is consistent with monomeric forms in solution,20 and is also 
in agreement with a comparison of the DFT-simulated 
(B3LYP/6-31G*) structures of [1]rotaxane 6 and its unthreaded 
isomer 8 (Figure 4).21
Conclusions
An expedient route to a peptide containing amide hydrogen 
bond templated [1]rotaxane has been demonstrated by the 
synthesis and structural characterization of a tetra-glycine 
containing [1]rotaxane. Looking forward, substitution of Boc-
Gly-Gly-Gly by other aliphatic side-chained peptide sequences 
should be straightforward, and in principle with modifications 
to protecting group strategy more exotic amino acid side-chains 
(or non-peptide motifs) could be incorporated. Hence delicate 
bioactive functionality could be displayed in the loop region, 
with protection against enzymatic degradation9 and/or 
conformational control being provided by the entangled 
[1]rotaxane structure. Work on some of these avenues of 
research, as well as developing alternative synthetic routes to 
novel [1]rotaxanes, are ongoing in our laboratories.
Experimental
General information
Commercially available solvents and chemicals were used 
without further purification unless stated. Dry solvents, NEt3 
and DIPEA were purchased dry and stored under an inert 
atmosphere. Cu(CH3CN)4BF4 was stored in desiccator over 
P4O10. Deionised water was used in all cases.
Silica gel with a 60Å particle size was used as the stationary 
phase for column chromatography. Analytical TLC was used to 
monitor the progress of column chromatography and analytical 
TLC plates were examined under short wavelength ( = 254 nm) 
UV light. Preparatory TLC was carried out on silica gel possessing 
a fluorescent indicator to allow for examination with short 
wavelength UV light.
IR spectra of neat samples were recorded on an Agilent 
Technologies Cary 630 FTIR spectrometer. NMR spectra of 
samples dissolved in deuterated solvent were recorded on a 
Bruker AVANCE III 400 spectrometer at 298 K. 1D NMR spectra 
were referenced using residual solvent peaks, and assigned 
using standard 1H-1H COSY, 1H-13C HSQC and 1H-13C HMBC NMR 
experiments, with data being reported according to the atom 
labels as defined in the structures below. Electrospray mass 
spectra of dissolved samples, diluted in CH3CN or CH3OH, were 
recorded on a Shimadzu LCMS IT ToF instrument. Melting points 
were recorded on a Gallenkamp capillary melting point 
apparatus and are uncorrected.
Experimental procedures
[2]Rotaxane 4. Amino macrocycle 3 (107 mg, 0.219 mmol) and 
azide 1 (82 mg, 0.24 mmol) were dissolved in dry CH2Cl2 (10 mL) 
under an Ar (g) atmosphere. Then alkyne stopper 2 (86 mg, 
0.24 mmol) in dry CH2Cl2 (1 mL), Cu(CH3CN)4BF4 (7.6 mg, 
0.024 mmol), TBTA (13 mg, 0.024 mmol) and DIPEA (34 mg, 
46 L, 0.26 mmol) were added. The reaction was stirred at r.t. 
for 15 h under an Ar (g) atmosphere. Then, the reaction was 
diluted to 20 mL, washed with 0.02 M EDTA in 1M NH3 (aq) 
solution (2 × 20 mL) and brine (1 × 20 mL). The organic layer was 
dried (MgSO4) and solvent removed in vacuo. The crude 
material was purified by silica gel column chromatography 
Figure 4: Minimum energy DFT calculated structures of (a) [1]rotaxane 6 and (b) unthreaded isomer 8 (C-H hydrogen atoms omitted for clarity).



















































































































Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins
Please do not adjust margins
(CH2Cl2/CH3OH 99:1 to 96:4) to yield pure product 4 as a 
colourless film (52 mg). In addition, axle 7 (102 mg) was also 
isolated. Further pure product 4 was isolated after prep TLC of 
mixed fractions (17 mg). Total yield of [2]rotaxane 4: 69 mg, 
27%.
Rf: 0.20 (CH2Cl2/CH3OH 98:2).
max/cm‒1 (neat): 3350 (N‒H), 2920 (C‒H), 1740 (C=O ester), 
1650 (C=O amide), 1600, 1520, 1450, 1360, 1280, 1230, 1130, 
1030.
H (400 MHz; CDCl3/CD3OD 1:1): 8.18 (2H, s, C17H), 8.05 (1H, s, 
C14H), 7.75-7.76 (2H, m, C23H & C29H), 7.67 (1H, t, 4J = 1.5 Hz, 
C4H), 7.64 (1H, s, C27H), 7.43 (1H, t, 3J = 5.4 Hz, C20NH), 7.36 (2H, 
d, 4J = 1.5 Hz, C2H), 7.32 (1H, s, C32H), 6.88 (4H, d, 3J = 7.9 Hz, 
C8H), 6.71 (4H, d, 3J = 7.9 Hz, C9H), 5.02 (2H, s, C25H), 4.49 (2H, 
d, 2J = 14 Hz, C6H - diastereotopic) 4.25-4.30 (4H, m, C6H - 
diastereotopic & C11H - diastereotopic) 4.05-4.08 (4H, m, C11H - 
diastereotopic & C34H), 3.99 (2H, t, 3J = 7.0 Hz, C22H), 3.54-3.72 
(8H, m, C13H & C12H), 2.67 (2H, br s, C20H), 1.66-1.73 (2H, m, 
C21H), 1.47 (9H, s, C37H).
C (100 MHz; CDCl3/CD3OD 1:1): 170.0 (C35), 168.7 (C5), 167.9 
(C33), 165.0 (C19), 159.4 (C26), 149.1 (C1), 143.1 (C24), 138.1 (C7), 
137.1 (C10), 137.1 (sic, C28), 136.7 (C18), 136.0 (C3), 132.8 (q, 2J = 
32 Hz, C30), 132.3 (q, 2J = 34 Hz, C15), 129.6 (C9), 129.1 (C17), 129.0 
(C8), 125.7 (C23), 125.3 (br, C14), 124.0 (q, 1J = 271 Hz, C16), 118.0 
(C2), 117.6 (br, C29), 117.3 (C27) 115.9 (br, C32), 114.2 (C4), 82.9 
(C36), 74.3 (C11), 71.6 (C13), 70.4 (C12), 62.4 (C25), 48.7 (C22), 44.8 
(C6), 43.1 (C34), 38.1 (C20), 29.6 (C21), 28.4 (C37). Quartet for C31 
lost in baseline.
F (377 MHz; CDCl3/CD3OD 1:1): ‒63.1 (C16F3), ‒63.4 (C31F3).
m/z (ES): 1209.4047 ([M + Na]+ C57H59F9N8NaO10 requires 
1209.4103).
Boc-Peptide [2]Rotaxane 5. [2]Rotaxane 4 (69 mg, 0.058 mmol) 
was dissolved in dry CH2Cl2 (2 mL), and cooled to 0 °C under an 
Ar (g) atmosphere. Then dry NEt3 (8.8 mg, 12 L, 0.087 mmol), 
triglycine tert-butyl ester (17 mg, 0.058 mmol), HOBt.hydrate 
(10 mg, 0.076 mmol) and EDCI.HCl (15 mg, 0.076 mmol) were 
added, maintaining the temperature at 0 °C. The reaction was 
stirred at r.t. for 6 h, at which time analytical TLC confirmed 
presence of 4. The reaction flask was cooled to 0 °C and further 
dry NEt3 (8.8 mg, 12 L, 0.087 mmol), triglycine tert-butyl ester 
(17 mg, 0.058 mmol), HOBt.hydrate (10 mg, 0.076 mmol) and 
EDCI.HCl (15 mg, 0.076 mmol) were added. The reaction was 
stirred at r.t. for a further 16 h, at which time analytical TLC 
confirmed presence of 4. The reaction flask was cooled to 0 °C 
and further dry NEt3 (8.8 mg, 12 L, 0.087 mmol), triglycine tert-
butyl ester (17 mg, 0.058 mmol), HOBt.hydrate (10 mg, 
0.076 mmol) and EDCI.HCl (15 mg, 0.076 mmol) were added. 
The reaction was stirred at r.t. for a further 24 h, then diluted 
with CH2Cl2 (20 mL), and then washed with H2O (1 × 20 mL), 10% 
citric acid (aq) (2 × 20 mL), saturated NaHCO3 (aq) (2 × 20 mL) 
and brine (1 × 20 mL). The organic layer was dried (MgSO4), and 
the solvent removed in vacuo. The crude material was purified 
by silica gel chromatography (CH2Cl2/CH3OH 98:2 to 92:8) to 
yield pure product 5 as a white film (68 mg, 80%).
Rf: 0.22 (CH2Cl2/CH3OH 96:4).
max/cm‒1 (neat): 3320 (N‒H), 3070 (C‒H), 2920 (C‒H), 1650 
(C=O), 1600, 1520, 1450, 1370, 1280, 1130, 1030.
H (400 MHz; CDCl3): 9.45 (1H, s, C9NH), 8.19 (4H, s, C11H & 
C26H), 8.07-8.10 (2H, br s, C5HNH or C7HNH & C42HNH), 8.04 (1H, 
s, C13H), 8.00 (1H, s, C23H), 7.90 (1H, br s, C5HNH or C7HNH), 7.84 
(2H, br s, C14NH), 7.81 (1H, s, C32H), 7.70 (1H, s, C38H), 7.58 (1H, 
s, C36H), 7.24 (2H, s, C28NH & C41H), 6.94 (4H, d, 3J = 7.9 Hz, C17H), 
6.74 (4H, d, 3J = 7.9 Hz, C18H), 6.28 (1H, br s, C3HNH), 4.99 (2H, 
s, C34H), 4.60-4.65 (2H, m, C15H - diastereotopic), 4.29 (2H, d, 2J 
= 10 Hz, C20H - diastereotopic), 4.20-4.25 (2H, m, C15H - 
diastereotopic), 4.15 (2H, d, 3J = 5.5 Hz, C43H), 4.09 (2H, d, 2J = 
10 Hz, C20H - diastereotopic), 4.01 (6H, m, C6H, C8H & C31H), 3.87 
(2H, d, 3J = 5.5 Hz, C4H), 3.56-3.75 (8H, m, C21H & C22H), 2.65-
2.69 (2H, app q, C29H), 1.70-1.73 (2H, m, C30H), 1.51 (9H, s, C46H), 
1.35 (9H, s, C1H).
C (100 MHz; CDCl3): 171.9 (C5), 170.7 (C7 or C9), 169.9 (C44), 
168.0 (C7 or C9), 166.8 (C14), 166.2 (C42), 164.0 (C28), 158.5 (C35), 
156.7 (C3), 142.1 (C33), 138.8 (*), 137.3 (C16), 136.2 (C19), 136.0 
(*), 135.8 (*), 135.1 (*), 131.4 (q, 2J = 32 Hz, C24 and/or C39), 
128.8 (C18), 128.3 (C17 & C26), 124.8 (C32), 124.5 (C23), 123.1 (q, 
1J = 271 Hz, C25 and/or C40), 121.6 (C11), 120.3 (br, C13), 117.0 (br, 
C38), 116.4 (C36), 115.0 (br, C41), 82.7 (C45), 80.1 (C2), 73.6 (C20), 
70.8 (C22), 69.5 (C21), 62.0 (C34), 47.7 (C31), 44.5 (C15), 44.3 (C4), 
43.7 (C6 or C8), 43.4 (C6 or C8), 42.8 (C43), 37.3 (C29), 28.7 (C30), 
28.2 (C1), 28.1 (C46). * = C10 or C12 or C27 or C37.
F (377 MHz; CDCl3): ‒62.5 (C25F3), ‒62.7 (C40F3).
m/z (ES): 1480.5282 ([M + Na]+ C68H76F9N11NaO15 requires 
1480.5271).
[1]Rotaxane 6. [2]Rotaxane 5 (20 mg, 0.014 mmol) was 
dissolved in CH2Cl2 (0.5 mL) and cooled to 0 °C. TFA (0.25 mL) 
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was added dropwise and the reaction mixture was stirred at r.t. 
for 2 h. Volatiles were removed in vacuo and deprotection 
confirmed by 1H NMR. The residue was re-dissolved in dry 
CH2Cl2 (7 mL), and cooled to 0 °C under an Ar (g) atmosphere. 
Then dry DIPEA (18 mg, 24 L, 0.14 mmol) and HATU (16 mg, 
0.042 mmol) were added, maintaining the temperature at 0 °C. 
The reaction was stirred at r.t. for 90 h, then diluted with CH2Cl2 
to 20 mL, then washed with 1M HCl (aq) (2 × 20 mL), sat. 
NaHCO3 (aq) (2 × 20 mL) and brine (1 × 20 mL).  The organic 
layer was dried (MgSO4), and the solvent removed in vacuo. The 
crude material was purified by silica gel chromatography 
(CH2Cl2/CH3OH 96:4 to 90:10) to yield pure product 6 as a white 
film (6.0 mg, 34%).
Rf: 0.31 (CH2Cl2/CH3OH 94:6).
max/cm‒1 (neat): 3300 (N‒H), 3080 (C‒H), 2920 (C‒H), 2870 
(C‒H), 1650 (C=O), 1600, 1530, 1450, 1360, 1330, 1280, 1170, 
1130, 1030.
H (400 MHz; CDCl3/CD3OD 1:1): 8.23 (2H, d, 4J = 1.5 Hz, C2H), 
8.14 (1H, s, C23H), 8.11 (2H, br s, C17H), 8.02 (2H, app t, C4H & 
C14H), 7.65 (1H, s, C29H), 7.38 (1H, s, C27H), 7.15 (1H, s, C32H), 
6.91 (4H, d, 3J = 8.0 Hz, C8H), 6.76 (4H, d, 3J = 8.0 Hz, C9H), 4.83 
(2H, s, C25H), 4.60-4.62 (2H, obscured doublet, C6H - 
diastereotopic), 4.30 (2H, d, 2J = 10 Hz, C11H - diastereotopic), 
4.19 (2H, s, C34H), 4.12-4.17 (4H, m, C22H & C6H - 
diastereotopic), 4.09 (2H, d, 2J = 10 Hz, C11H - diastereotopic), 
4.03 (2H, s, C38H or C40H), 3.99 (2H, s, C36H), 3.92 (2H, s, C38H or 
C40H), 3.71-3.76 (2H, m, C13H - diastereotopic), 3.55-3.66 (6H, 
C12H & C13H - diastereotopic), 2.61 (2H, t, 3J = 7.4 Hz, C20H), 1.76-
1.83 (2H, app quin, C21H).
C (100 MHz; CDCl3/CD3OD 1:1): 172.3 (C35), 172.1 (C37/C39/C41), 
171.6 (C37/C39/C41), 169.4 (C37/C39/C41), 168.3 (C5 & C33), 164.7 
(C19), 159.2 (C26), 142.9 (C24), 139.3 (C1 or C3), 138.1 (C7), 137.1 
(C10), 136.8 (C18 or C28), 136.5 (C18 or C28), 136.1 (C1 or C3), 132.7 
(q, 2J = 33 Hz, C30), 132.2 (q, 2J = 34 Hz, C15), 129.4 (C9), 128.9 (C8 
& C17), 126.5 (C23), 125.3 (br, C14), 122.7 (C2), 121.5 (C4), 117.9 
(br, C29), 117.0 (C27), 115.2 (br, C32), 74.2 (C11), 71.6 (C13), 70.3 
(C12), 62.4 (C25), 48.6 (C22),  45.0 (C6), 44.3 (C34), 44.3 (sic, C38 or 
C40), 43.8 (C38 or C40), 43.6 (C36), 37.8 (C20), 29.5 (C21). Quartets 
for C16 & C31 not fully resolved in 120-130 ppm region.
F (377 MHz; CDCl3/CD3OD 1:1): ‒63.1 (C16F3), ‒63.5 (C31F3).
m/z (ES): 1306.3971 ([M + Na]+ C59H58F9N11NaO12 requires 
1306.4015).
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The rapid synthesis and characterization of an amide hydrogen 
bond templated [1]rotaxane – demonstrating a potential 
pathway to synthetic analogues of lasso peptides.
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